Last updated on June 2017

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotrophic Hypogonadism


Brief description of study

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotrophic Hypogonadism

Detailed Study Description

The purpose of this study is to evaluate the safety and efficacy of BGS649 in male obese subjects with hypogonadotrophic hypogonadism. All subjects will be treated for a maximum of 24 weeks. Some subjects who complete 24 weeks of treatment will be invited to participate in a 6-month blinded safety extension study (Protocol MBGS206). The study is planned to enroll 268 subjects.

Clinical Study Identifier: TX150137

Contact Investigators or Research Sites near you

Start Over

Coastal Carolina Research Center

Coastal Carolina Research Center
Mount Pleasant, SC USA
  Connect »